Sukanya Raghavan

Goeteborg, O 41345, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Impact of Brodalumab on Serum Levels of IL-6, IL-17A, IFN-α, IFN-γ, and TNF-α in Patients with Psoriasis Who Failed Treatment with TNF-α Inhibitors.

Impact of Brodalumab on Serum Levels of IL-6, IL-17A, IFN-α, IFN-γ, and TNF-α in Patients with Psoriasis Who Failed Treatment with TNF-α Inhibitors.

Journal: International journal of molecular sciences

Published: November 27, 2025

Immune-stromal heterogeneity in breast cancer across diverse ancestries: impact on prognosis and treatment response.

Immune-stromal heterogeneity in breast cancer across diverse ancestries: impact on prognosis and treatment response.

Journal: NPJ breast cancer

Published: July 02, 2025

Coordinated humoral and cellular immune responses to COVID-19 vaccination in non-small cell lung cancer patients treated with immune checkpoint inhibitors.

Coordinated humoral and cellular immune responses to COVID-19 vaccination in non-small cell lung cancer patients treated with immune checkpoint inhibitors.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: May 25, 2025

High baseline PD-1+ CD8 T Cells and TIGIT+ CD8 T Cells in circulation associated with response to PD-1 blockade in patients with non-small cell lung cancer.

High baseline PD-1+ CD8 T Cells and TIGIT+ CD8 T Cells in circulation associated with response to PD-1 blockade in patients with non-small cell lung cancer.

Journal: Cancer immunology, immunotherapy : CII

Published: March 17, 2025

Comprehensive genetic variant analysis reveals combination of KRAS and LRP1B as a predictive biomarker of response to immunotherapy in patients with non-small cell lung cancer.

Comprehensive genetic variant analysis reveals combination of KRAS and LRP1B as a predictive biomarker of response to immunotherapy in patients with non-small cell lung cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: December 22, 2024

Equalizing prognostic disparities in KRAS-mutated stage III NSCLC patients: addition of durvalumab to combined chemoradiotherapy improves survival.

Equalizing prognostic disparities in KRAS-mutated stage III NSCLC patients: addition of durvalumab to combined chemoradiotherapy improves survival.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: September 05, 2024

Immune checkpoint blockade improves the activation and function of circulating mucosal-associated invariant T (MAIT) cells in patients with non-small cell lung cancer.

Immune checkpoint blockade improves the activation and function of circulating mucosal-associated invariant T (MAIT) cells in patients with non-small cell lung cancer.

Journal: Oncoimmunology

Published: February 12, 2024

Combinatory analysis of immune cell subsets and tumor-specific genetic variants predict clinical response to PD-1 blockade in patients with non-small cell lung cancer.

Combinatory analysis of immune cell subsets and tumor-specific genetic variants predict clinical response to PD-1 blockade in patients with non-small cell lung cancer.

Journal: Frontiers in oncology

Published: October 18, 2022

KRAS Mutations Impact Clinical Outcome in Metastatic Non-Small Cell Lung Cancer.

KRAS Mutations Impact Clinical Outcome in Metastatic Non-Small Cell Lung Cancer.

Journal: Cancers

Published: March 17, 2022

Conditional Deletion of Pdcd1 Identifies the Cell-Intrinsic Action of PD-1 on Functional CD8 T Cell Subsets for Antitumor Efficacy.

Conditional Deletion of Pdcd1 Identifies the Cell-Intrinsic Action of PD-1 on Functional CD8 T Cell Subsets for Antitumor Efficacy.

Journal: Frontiers in immunology

Published: August 02, 2021

Immune checkpoint blockade and biomarkers of clinical response in non-small cell lung cancer.

Immune checkpoint blockade and biomarkers of clinical response in non-small cell lung cancer.

Journal: Scandinavian journal of immunology

Published: June 15, 2020

Regulatory T cells specifically suppress conventional CD8αβ T cells in intestinal tumors of APCMin/+ mice.

Regulatory T cells specifically suppress conventional CD8αβ T cells in intestinal tumors of APCMin/+ mice.

Journal: Cancer immunology, immunotherapy : CII

Published: November 24, 2019

Showing 1-12 of 34

Last Updated: 09/26/2026